Skip to content

Checking the Benefits of Bruhtyadi Vati in People with High Cholesterol (Dyslipidemia)

Randomised Open Controlled Clinical Study to evaluate the effect of Bruhatyadi Vati in management of Medodushti with special reference to Dyslipidema - Nil

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087052
Enrollment
106
Registered
2025-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

None listed

Sponsors

DrNileshkumar Samarjit Tiwari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group having 25 to 60 years of age. Obese Dyslipidemic and Non-Obese Dyslipidemic Patients (BMI-18.50 to 40.00 kg/m2) as per latest Updated WHO classification of BMI). According to NCEP ATPIII Classification, the Pilot Project Study by Prevalence in local area and with the guidelines of CCRAS for Dyslipidemia; following were the levels to be selected for said Project. Patient having Serum Total Cholesterol Level 200-239 mg/dl Patient having Serum LDL Cholesterol Level 130-159 mg/dl Patient having serum VLDL Cholesterol Level 40-60 mg/dl Patient having Serum HDL Cholesterol Level 20-40 mg/dl Patient having Serum Triglyceride Level 150-190 mg/dl Patients having one or more of above levels will be selected for said project

Exclusion criteria

Exclusion criteria: Pregnant and lactating mothers. Patients having Diabetes Mellitus. Patients having history of Respiratory Disease Complications, Coronary Heart disease, Renal Disease Patients having Acute Complications like Severe Hypertension (B.P 150/90 mm Hg in those with age 60 years and older, and 140/90 mm Hg for adults less than 60 years. according to Eighth Joint National Committee Guideline), Hepatitis or with history of major surgery etc. Patients having disorders like Carcinoma anywhere in the body etc.

Design outcomes

Primary

MeasureTime frame
Changes in Lipid Profile by Bruhatyadi Vati towards the Normal levels. Timepoint: Outcome will be assessed at baseline, 4 weeks & 8 weeks

Secondary

MeasureTime frame
NilTimepoint: nil

Countries

India

Contacts

Public ContactDr Nileshkumar Samarjit Tiwari

R.A Podar Medical College(Ayu), Mumbai

geeta.parulkar@gmail.com8652694332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026